Reata Pharmaceuticals
RETA
$172.36
Share price
0.00%
Change (1 day)
373.78%
Change (1 year)
Categories
EPS for Reata Pharmaceuticals (RETA)
EPS in 2023 (TTM): -$2.51
According to Reata Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.51. In 2022 the company made an earnings per share (EPS) of -$8.54 a decrease over its 2021 EPS that were of -$8.18.
EPS history for Reata Pharmaceuticals from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.51 | -70.61% |
| 2022 | -$8.54 | 4.4% |
| 2021 | -$8.18 | 11.44% |
| 2020 | -$7.34 | -21.5% |
| 2019 | -$9.35 | 228.07% |
| 2018 | -$2.85 | 43.94% |
| 2017 | -$1.98 | 576% |
| 2016 | -$0.29 | 11.1% |
| 2015 | -$0.26 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -13.15% | 🇺🇸 USA |